Historically, because of the random nature of the nucleation process, lyophilization has been difficult to control. For a typical pharmaceutical formulation filled in vials, for example, crystals might form at temperatures ranging from –5 to –20 °C).
As the nucleation temperature has a direct impact on the developing ice structure and crystal size — as well as the appearance of the dried product cake — it can negatively influence the product’s critical quality attributes (CQAs), such as residual moisture or dissolution behavior.
A new patent-pending technology from GEA, which is fully compatible with all our currently available freeze dryers, provides a novel and scalable method to control the nucleation process without having to develop new pharmaceutical formulations.
Process without LYOSPARK®
Simultaneous Crystal Nucleation
LYOSPARK® enables the user to control the temperature at which nucleation crystals form inside the product, thereby ensuring that, at any time, every vial in the chamber is subjected to the same process conditions, irrespective its specific location on the shelf.Combining LYOSPARK® technology with conventional freeze-drying processes is very simple. The vials are loaded into the freeze dryer as usual and cooled to the optimal (product dependent) nucleation temperature. As soon as the nucleation temperature is reached, the chamber is vented with gas from a condenser.
A filter-equipped cooling trap is mounted on the chamber. Ice crystals form on the cooled surface of the trap and are entrained in the gas stream during venting. Inside the supercooled product solution, the ice crystals undergo immediate and homogenous nucleation in each vial.
As the formation of ice crystals at higher temperatures results in larger pores, drying times can be shortened. Furthermore, LYOSPARK® offers better scalability, sterility and higher throughput speeds than conventional systems, resulting in optimized performance and productivity.
Process with LYOSPARK®
Process Optimization
LYOSPARK®, which eliminates issues such as the denaturation of active ingredients or unpredictable scale-up, also provides several technical advantages, including improved product quality, better vial uniformity per batch and a more homogenous, aesthetically pleasing cake.In summary, LYOSPARK® controlled nucleation technology facilitates uniform ice crystal formation in laboratory and production-scale freeze dryers with a minimum degree of supercooling. This is reflected in more consistent and larger ice crystal sizes with a more open product structure. As a result, faster drying and reconstitution times can be achieved.
QbD-compliant, GEA’s LYOSPARK® delivers a more uniform, higher quality product, reduces process times and provides a cost-effective solution to controlled nucleation.
At a glance advantages
- Larger ice crystals
- Shorter drying times
- Better process control
- Better reconstitution
- Less vial cracking
- Less stress on biological agents
- Better looking cake
This cost-efficient technology will be offered as an option for all GEA freeze dryers and will also be available as a retrofit option for existing plant.
Downloads
Aanverwante producten
LYOVAC® Pharma Freeze Dryer
GEA’s LYOVAC® industrial-scale freeze dryers are built to customer specifications and are available with production areas of 1–60 m² and condenser capacities of more than 1000 kg.
LYOVAC® Freeze dryers for small scale production modules
LYOVAC® Freeze dryers for small scale production modules
LYOVAC® Small-Scale Freeze Dryers
Extending its range of LYOVAC™ Freeze Dryers, GEA now offers both integrated and standalone equipment for the production of small-scale batches and formulation or process development.
GEA-inzichten
De doorbraak die het sproeidrogen veranderde
In 1976 gingen de ingenieurs van NIRO een concurrentie-uitdaging aan door de mogelijkheden van sproeidrogen opnieuw te bekijken. Hun idee leidde tot de meertraps droger MSD. Vijftig jaar later zorgt datzelfde basisprincipe ervoor dat vloeistoffen worden omgezet in poeders die wereldwijd worden gebruikt in essentiële voedingsproducten en belangrijke geneesmiddelen. MSD is het resultaat van tientallen jaren technische expertise, klantinzicht en voortdurende ontwikkeling, en is een verhaal van innovatie met blijvende impact.
Verder dan de machine: betere prestaties van de installatie ontsluiten
Een efficiënte machine betekent niet automatisch een efficiënte fabriek. Echte verbetering begint vaak met verder kijken dan de afzonderlijke apparatuur en met inzicht in hoe processen, energiesystemen en operationele beslissingen elkaar beïnvloeden. Het is een holistische benadering die bedoeld is om kansen te ontdekken die anders wellicht over het hoofd gezien zouden worden.
Hoe een klep de manier waarop eten en drinken worden gemaakt opnieuw vormgeeft
De kleppen in voedingsmiddelen- en drankinstallaties worden doorgaans met perslucht bediend. GEA Hydract® Actuation Technology stuurt kleppen daarentegen aan met water, in een gesloten, digitaal geregeld circuit. Het resultaat is een klep die precies op zijn plaats kan worden gehouden en in nauwkeurig afgestemde stappen kan worden aangestuurd. Dit leidt tot een lager energieverbruik en meer controle.
